Bacterin Enters EU Market Via Strategic Partnership

Bacterin International Holdings Inc., a Belgrade, Mont.-based maker of bone graft materials and coatings for medical applications, has formed a strategic alliance with DMP Spine Biologics for distribution of Bacterin’s proprietary biologic products in the European Union (EU).

“We are pleased to have established this strategic relationship with DMP,” said Daniel Goldberger, CEO of Bacterin. “They have extensive relationships throughout Europe and have a vast knowledge of the orthopedic and spine markets in various countries. The European markets represent a significant opportunity for our products. This relationship will allow us to enter the European market and expand our business internationally.”

“We could not be more excited about this opportunity to work with such an innovative, U.S.-based tissue bank with an incredible portfolio of products and knowledgeable management team,” said Marios Papadopoulos, chairman and CEO of DMP Spine Technologies. “We have already engaged distributors through our network and will be expanding distribution into various EU countries in the very near future.”

DMP Spine Investments Inc., parent to DMP Spine Biologics, is a Delaware-based corporation focused on providing U.S. products to European markets, The company’s leadership claims more than 30 years of experience distributing for major U.S. orthopedic and spine manufacturers.